Interviews with GI Leaders
Sam Jactel, CEO of Ayble Health:“Being patient centered is different than being patient driven” At…
“Physicians are at the epicenter of changing the way we live our lives”AGA launches GI…
I asked Jonathan Ng, founder and CEO of Iterative Health (formerly known as Iterative Scopes, an AI in…
Gastroenterologist Dr. Michael Owens did a thought experiment during the pandemic period. He asked himself, what would I…
Dr. Larry Kosinski needs no introduction. As a leader, he’s known for innovating, for breaking away…
As I write this note, I’m beginning to wonder what GI care means anymore. Just a…
Data is indeed the new oil. Consider the strangeness of the scenario. GI doctors are…
In November 2021, a month after Dr. Haytham Gareer joined Geneoscopy as CMO, the company raised $105 million…
While COVID was on and people sought help through meditation apps, the business world of…
Sonia Grego (Co-Founder at Coprata):Oura Ring for sleep. WHOOP for activity. Now, Coprata Smart Toilet…
A few years ago Virgo was taking shape as a storage system for endoscopy videos. With persistence and the right pivoting, it’s amazing what Matt and his team at Virgo have been able to do. Their Northstar goal is to change the standard of care by saving data. You’ve heard of the new adage: ‘data is the new oil’. With the advent of AI in GI, it shouldn’t be a surprise then that Virgo will dramatically influence GI care in the coming years.
GI doctors are conditioned to function the way they have for the last 10-15-20-30 years. But the industry is shifting gears. Technology and business forces are disrupting the norm as we know it. Physicians want to change but fear grips them as they do. Most don’t talk about their concerns openly fearing ridicule of their peers. Watch Dr. Fehmida Chipty’s fascinating narration unfold fundamental issues of gastroenterology.
There’s a lot of noise about recession right now. Inflation is high. Job losses are on the horizon. Public markets are brutal. Abe M’Bodj, VP at Westcove Partners an investment bank helps us listen to the signal from the noise.
In this interview, Founder & CEO of FoodMarble, Aonghus Shortt shares with us the story of their growth. An engineer gets an idea after seeing his girl friend suffer. Ideates and develops the device in Ireland and China. Raises $6 million and sells globally – more than 2/3rd in the US.
In this interview, gastroenterologist and AI researcher Dr. Sravanthi Parasa talks about the big implications for the business of gastroenterology. AI will indeed operate and guide us like a self driving car. In such a world, how would your role evolve as the endoscopist?
In this interview, Sam Holliday talks about their plans to scale across all 50 states by the end of 2022. They also plan to hire gastroenterologists and partner with GI practices. Learn about what’s attracting investor interest in digitization of gastroenterology.
In a data driven world, it’ll become acutely obvious that our system is broken in terms of racial disparity. The drugs we have don’t work for all demographics. GI physician community is quite imbalanced in terms of race. In this interview, Dr. Aja McCutchen shares her story – from the suburbs of Cleveland to leading the field.
US Digestive Health is one the eight private equity backed GI platforms in the country. In this open-ended conversation, Dr. Mehul Lalani (VP, US Digestive), Gabriel Luft (Principal, Amulet Capital Partners), and Jerry Tillinger (CEO, US Digestive Health) talk about how the platform has evolved.
Elena Mustatea is the CEO and founder of Bold Health, a digital GI company that delivers digital therapeutics for the treatment of various GI conditions such as IBS. In this first-of-its-kind interview, learn more about Bold Health and the world of digital therapeutics, CBT, integrative medicine and the advent of digital health in GI.
Dr. Scott Ketover is the President and CEO of MNGI Digestive Health (previously Minnesota Gastroenterology). In a world of private equity, MNGI has firmly decided to stay independent. Dr. Ketover shares why they don’t need to and what their growth strategy is.
Dr. Brennan Spiegel is the author of VRx: How Virtual Therapeutics Will Revolutionize Medicine. He’s the Director of Health Services Research, Cedars-Sinai Health System. This is a historic, one-of-a-kind interview that lays out the digital future for GI from the lens of virtual reality (VR).
Rock Rockett is the Founder and Principal of Rockett Healthcare Strategies. In this interview, we explore the big question on many people’s minds: is it still possible to stay small and independent if you choose to?
In this interview, Dr. Robert Gialanella, CEO/President and Dr. Nadeem Baig, Vice President of Allied Digestive Health talk about their journey – from being competitors to partners to choosing private equity and more.
In this one-of-a-kind interview, Dr. Bergein Overholt walks us through his four-decade-long journey, reflects on the new technologies, private equity, and shares his views on alignment among physicians.
Recently, Medtronic released a video showing how Pillcam (in partnership with Amazon) will enable home-based colonoscopy screening. Watch Giovanni Di Napoli, President of Medtronic GI sharing that vision.
What if you could own companies you spend money on? What if you could save money on routine purchases by getting bulk rates? With those ideas, Christopher Metz and Stephen Somers founded Gastrologix, a Group Purchasing Organization (GPO). In this interview, Chris and Steve tell us what exactly a GPO is and how Gastrologix spun out of the Digestive Health Network (DHN).
Dr. Prashant Krishnan is the Chief Medical Officer of Gastro Care Partners/Peak Gastroenterology Associates. In December 2019, Peak Gastroenterology partnered with Varsity Healthcare Partners to launch the sixth PE platform in GI. In this insightful interview, Dr. Krishnan reveals a core strategy (called YOU) that led to their explosive growth from 4 to 43 providers. That growth opened doors to private equity.
Dr. Ivo Boškoski is a Consultant Gastroenterologist at Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome. As of this writing, we don’t know whether the third wave of COVID in US will peak this winter. But can we be prepared in case it does? Where better to look than Europe?
Dr. Ellen Scherl is the Research Director and Founding Director of the Jill Roberts Center for Inflammatory Bowel Disease (IBD), Weill Cornell Medicine. She says, it’s time for gastroenterologists to approach GI care comprehensively and reclaim their role as healers.
Joe Rubinsztain, M.D is the CEO and Co-Founder at ChronWell. In this future-oriented interview, Dr. Rubinsztain walks us through how ChronWell works and their progress during COVID-19.
John Allen, M.D is the Chief Clinical Officer of the University of Michigan Medical Group and is also on the board of Allina Health. This interview is so insightful that it’ll help you make several business and personal decisions for the long haul.
Christopher Fourment, M.D is the President and CEO of Clinical Research Strategy Group and Precision Research (Texas). In this interview, you’ll learn why Dr. Fourment chose to focus on clinical research as a career path.
George “G.B.” Pratt is the Founder and CEO of ModifyHealth. The company recently raised $2 million in Series A funding – right in the middle of the pandemic. In this interview, you’ll learn more about ModifyHealth’s business model. A big question GB reflects on is whether ModifyHealth goes against the grain of today’s healthcare model.
In this video, Dr. Don Lazas shares his insights on how GI physicians can take the spirit of entrepreneurship beyond private practice.
In this interview, with Dr. Narayanachar Murali, Dr. Don Lazas and Dr. Chris Fourment, you’ll learn three different perspectives on clinic trials/research as an ancillary in a GI practice. We’ll explore the pros/cons, costs, risks, and operating models.
Dr. Latha Alaparthi is from Physician Alliance of Connecticut (PACT) and Gastroenterology Center of Connecticut (GCC). In this interview, learn how a multispecialty GI group made a decision to ally with a regional hospital. Understand what steps PACT GCC took to navigate COVID-19 and what they are doing now to continue endoscopies safely.
In the interview’s second part, Dr. Weinstein talks about how many aspects of the medical practice can be done remotely. He reflects on the future of GI post COVID, his experiences with the giants of gastroenterology (e.g. Dr. Gene Overholt, the father of endoscopy) and what must fellows in GI must focus on.
Dr. Michael Weinstein is the President & CEO of Capital Digestive Care, the largest gastroenterology group in the Mid-Atlantic states. In this interview, Dr. Weinstein outlines the benefits of their MSO to private GI practices. Is there going to be a cash payout during transaction? How does it differ from private equity?
Dr. Michael Byrne is CEO & Founder of Satisfai Health, an artificial intelligence company that aims to deliver the future of gastroenterology. I spoke to Dr. Byrne to understand where exactly AI is in gastroenterology. What must private practice gastroenterologists do now? What does the world of GI look like post-COVID?
Scott Fraser is the Founder and Managing Director of Fraser Healthcare, a consulting practice focused on growth strategies for healthcare companies and private equity firms. Watch this super insightful interview in full to understand where the business of gastroenterology is going.
Dr. James Leavitt is the President and Chief Clinical Officer of Gastro Health, a PE-backed platform based in Florida. Private equity in gastroenterology began with Audax investing in Gastro Health back in 2016. Over the last few years, Gastro Health expanded to 250 providers and to other states like Alabama and Washington.
This Memorial Day, I spoke to Dr. Mitchell Spinnell from The Gastroenterology Group of Northern New Jersey. Bergen County where Dr. Spinnell and his partners practice is a red zone. After prolonged closure, they are opening up their office and surgery center this week.
I recently spoke to Dr. Harish Gagneja from Austin Gastroenterology, the largest single specialty group in Austin, Texas. We had fun debating on whether healthcare will change after this pandemic. Dr. Gagneja had contrarian but very practical views on telemedicine.
I spoke to Abe M’Bodj from Provident Healthcare Partners, an investment bank that’s been very active in the gastroenterology space. Abe has always had a pulse on where private equity is headed in healthcare.
I spoke to Dr. Ashish Atreja, the Chief Innovation Officer at Icahn School of Medicine at Mount Sinai. He’s a well-known keynote speaker in the field of digital medicine. Also, a board member of Rx.Health that released the Virtual Care Hub (with AGA) this week.